Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Delhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugs

      Delhi High Court: E-pharmacies claim they are like Swiggy, only deliver drugs

      Farhat Nasim4 July 2019 5:04 PM IST
      The e-pharmacies told a bench of Chief Justice D N Patel and Justice C Hari Shankar that just like Swiggy does not require a restaurant license to...
      NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details

      NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details

      Farhat Nasim4 July 2019 2:40 PM IST
      New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
      CDSCO Warning: Beware of hacking risk in Medtronic insulin pumps

      CDSCO Warning: Beware of hacking risk in Medtronic insulin pumps

      Farhat Nasim4 July 2019 11:40 AM IST
      New Delhi: Months after issuing an advisory against three models of pacemakers sold by the world’s largest medical device manufacturer, Medtronic,...
      Caught on Camera: Robbers strike at chemist shop in Okhla; flee with Rs 1 lakh cash at gunpoint

      Caught on Camera: Robbers strike at chemist shop in Okhla; flee with Rs 1 lakh cash at gunpoint

      Farhat Nasim3 July 2019 5:21 PM IST
      New Delhi: In the wee hours of Tuesday morning, three armed men barged into a chemist shop in Sarai Jullena village in Okhla which is a suburban...
      FIRST: Dr Reddys unveils generic version of Hemabate injection indicated for abortion

      FIRST: Dr Reddys unveils generic version of Hemabate injection indicated for abortion

      Farhat Nasim3 July 2019 3:30 PM IST
      The product is a generic version of Pfizer's Hemabate injection in the strength of 250 mcg/mL, it added.NEW DELHI: Dr Reddy's Laboratories Wednesday...
      Strides Pharma gets USFDA warning letter for Puducherry facility

      Strides Pharma gets USFDA warning letter for Puducherry facility

      Farhat Nasim3 July 2019 11:38 AM IST
      The 10 abbreviated new drug applications (ANDAs) pending approval from the Puducherry facility will get deferred till the site is reclassified,...
      Sun Pharma former RnD head murders family of three, then commits suicide

      Sun Pharma former RnD head murders family of three, then commits suicide

      Farhat Nasim2 July 2019 5:07 PM IST
      Gurugram: In a spine chilling incident, former head of Research & Development (R&D) at Sun Pharmaceuticals Ltd. (Sun Pharma) along with his...
      Pfizer receives USFDA approval for biosimilar to Avastin

      Pfizer receives USFDA approval for biosimilar to Avastin

      Farhat Nasim2 July 2019 2:24 PM IST
      ZIRABEV is a mAb biosimilar of the reference product, Avastin, which works by inhibiting the formation of new blood cells (angiogenesis) by...
      Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

      Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

      Farhat Nasim2 July 2019 12:55 PM IST
      The new parental leave policy is effective July 1, 2019 and applies to birthing and non-birthing parents in the case of birth, adoption and surrogacy,...
      Alembic Pharma gets USFDA nod for generic version of Uloric tablets

      Alembic Pharma gets USFDA nod for generic version of Uloric tablets

      Farhat Nasim2 July 2019 11:49 AM IST
      The approved product, Febuxostat tablet is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals USA, Inc....
      Dino Morea, DJ Aqeel summoned by ED in Sterling Biotech bank fraud case

      Dino Morea, DJ Aqeel summoned by ED in Sterling Biotech bank fraud case

      Farhat Nasim2 July 2019 9:15 AM IST
      The actor and the popular disc jockey (DJ) have been asked to depose before the Enforcement Directorate (ED) as it has got evidence that the two were...
      Akshay Kumar joins fitness tech startup GOQii as investor, strategic advisor

      Akshay Kumar joins fitness tech startup GOQii as investor, strategic advisor

      Farhat Nasim1 July 2019 3:43 PM IST
      NEW DELHI: The 'Khiladi' of Bollywood Akshay Kumar has recently invested an undisclosed amount in GOQii, a fitness technology venture that offers a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok